Dextromethorphan

CAS No. 125-71-3

Dextromethorphan( Levomethorphan | RACEMETHORPHAN )

Catalog No. M26005 CAS No. 125-71-3

Dextromethorphan is an NMDA receptor antagonist used to treat cases of dry cough.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 131 In Stock
5MG 197 In Stock
10MG 298 In Stock
25MG 536 In Stock
50MG 764 In Stock
100MG 1053 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dextromethorphan
  • Note
    Research use only, not for human use.
  • Brief Description
    Dextromethorphan is an NMDA receptor antagonist used to treat cases of dry cough.
  • Description
    Dextromethorphan is an NMDA receptor antagonist used to treat cases of dry cough.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Levomethorphan | RACEMETHORPHAN
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Antifection
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    125-71-3
  • Formula Weight
    271.404
  • Molecular Formula
    C18H25NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc2CC3C4CCCCC4(CCN3C)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Antiplasmodial and cytotoxic activity of coumarin derivatives from dried roots of Angelica gigas Nakai in vitro.Immunopharmacol Immunotoxicol. 2011 Dec;33(4):663-6.
molnova catalog
related products
  • JAG-1, scrambled

    This peptide is a scrambled sequence of JAG-1(188-204).

  • Balsalazide

    Balsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.

  • RCM-1

    RCM-1 is an inhibitor of FOXM1. RCM-1 inhibits cellular proliferation via the increasing duration of cell cycle and mitosis in human and mouse cancer cell lines in vitro. RCM-1 inhibits colony formation of cancer cells in vitro in a dose-dependent manner. RCM-1 inhibits the migration of cancer cells in vitro in a dose-dependent manner.